Growth Metrics

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2026)

Anaptysbio filings provide 11 years of Depreciation & Amortization (CF) readings, the most recent being $130000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 10.96% to $130000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $543000.0, a 7.81% decrease, with the full-year FY2025 number at $559000.0, down 7.76% from a year prior.
  • Depreciation & Amortization (CF) hit $130000.0 in Q1 2026 for Anaptysbio, down from $131000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $184000.0 in Q4 2022 to a low of $130000.0 in Q1 2026.
  • Median Depreciation & Amortization (CF) over the past 5 years was $158000.0 (2023), compared with a mean of $154235.3.
  • Biggest five-year swings in Depreciation & Amortization (CF): rose 29.6% in 2022 and later fell 12.12% in 2024.
  • Anaptysbio's Depreciation & Amortization (CF) stood at $184000.0 in 2022, then dropped by 10.33% to $165000.0 in 2023, then fell by 12.12% to $145000.0 in 2024, then fell by 9.66% to $131000.0 in 2025, then decreased by 0.76% to $130000.0 in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $130000.0 (Q1 2026), $131000.0 (Q4 2025), and $140000.0 (Q3 2025) per Business Quant data.